The Frankfurt based Cedem AG Germany was founded in 2016 as a branch of Cedem AG Switzerland, which is a supplier, service provider and producer of pharmaceuticals and healthcare products in the business to business sector. Cedem AG Germany has begun initiating the process of implementing the Precision Medicine science in the MENA region, starting with the OptiCancer Test.
We strive to give patients the best care by providing them with the most effective treatment options by utilizing German capabilities and expertise. We trust that our innovative project will further develop cancer treatment technologies, and change patient’s perspective and help them believe that just because you have cancer, does not mean you can’t live a long and fulfilling life.
Our Vision is to implement a market-oriented technology which improves public healthcare in the MENA region, by tailoring cancer treatments with the use of genetic profiling.
Yousef Nazzal Alice Hattar
Business Development & Marketing Officer Project Coordinator